Deisseroth AB - Search Results

1

Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.

Mitchell MS, Abrams J, Thompson JA, Kashani-Sabet M, DeConti RC, Hwu WJ, Atkins MB, Whitman E, Ernstoff MS, Haluska FG, Jakowatz JG, Das Gupta TK, Richards JM, Samlowski WE, Costanzi JJ, Aronson FR, Deisseroth AB, Dudek AZ, Jones VE. Mitchell MS, et al. Among authors: deisseroth ab. J Clin Oncol. 2007 May 20;25(15):2078-85. doi: 10.1200/JCO.2006.10.1709. J Clin Oncol. 2007. PMID: 17513813 Clinical Trial.

2

Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.

Valone FH, Gandara DR, Deisseroth AB, Perez EA, Rayner A, Aronson FR, Luce J, Paradise C. Valone FH, et al. Among authors: deisseroth ab. J Immunother (1991). 1991 Jun;10(3):207-13. doi: 10.1097/00002371-199106000-00007. J Immunother (1991). 1991. PMID: 1651106 Clinical Trial.

3

Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.

Giralt SA, Kantarjian HM, Talpaz M, Rios MB, Del Giglio A, Andersson BS, Przepiorka D, Deisseroth AB, Champlin RE. Giralt SA, et al. Among authors: deisseroth ab. J Clin Oncol. 1993 Jun;11(6):1055-61. doi: 10.1200/JCO.1993.11.6.1055. J Clin Oncol. 1993. PMID: 8501491

4

Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatin.

Huan SD, Yau JC, Dunphy FR, Wallerstein RO, Dicke K, Spencer V, LeMaistre CF, Deisseroth AB, Hortobagyi GN, Holmes FA, et al. Huan SD, et al. Among authors: deisseroth ab. J Clin Oncol. 1991 Sep;9(9):1609-17. doi: 10.1200/JCO.1991.9.9.1609. J Clin Oncol. 1991. PMID: 1875221 Clinical Trial.

5

Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.

Akbulut H, Tang Y, Maynard J, Zhang L, Pizzorno G, Deisseroth A. Akbulut H, et al. Clin Cancer Res. 2004 Nov 15;10(22):7738-46. doi: 10.1158/1078-0432.CCR-04-0490. Clin Cancer Res. 2004. PMID: 15570008

6

Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.

Kantarjian HM, Talpaz M, Kontoyiannis D, Gutterman J, Keating MJ, Estey EH, O'Brien S, Rios MB, Beran M, Deisseroth A. Kantarjian HM, et al. J Clin Oncol. 1992 Mar;10(3):398-405. doi: 10.1200/JCO.1992.10.3.398. J Clin Oncol. 1992. PMID: 1740679

7

Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.

Ihde DC, Deisseroth AB, Lichter AS, Bunn PA, Carney DN, Cohen MH, Veach SR, Makuch RW, Johnston-Early A, Abrams RA, et al. Ihde DC, et al. Among authors: deisseroth ab. J Clin Oncol. 1986 Oct;4(10):1443-54. doi: 10.1200/JCO.1986.4.10.1443. J Clin Oncol. 1986. PMID: 3020181

8

Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy.

Kantarjian HM, Talpaz M, Hester J, Feldman E, Korbling M, Liang J, Rios MB, Smith TL, Calvert L, Deisseroth AB. Kantarjian HM, et al. Among authors: deisseroth ab. J Clin Oncol. 1995 Mar;13(3):553-9. doi: 10.1200/JCO.1995.13.3.553. J Clin Oncol. 1995. PMID: 7884415

9

Use of adenoviral vectors to target chemotherapy to tumor vascular endothelial cells suppresses growth of breast cancer and melanoma.

Li P, Liu Y, Maynard J, Tang Y, Deisseroth A. Li P, et al. Mol Ther. 2010 May;18(5):921-8. doi: 10.1038/mt.2010.5. Epub 2010 Feb 23. Mol Ther. 2010. PMID: 20179680 Free PMC article.

10

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

Hortobagyi GN, Buzdar AU, Theriault RL, Valero V, Frye D, Booser DJ, Holmes FA, Giralt S, Khouri I, Andersson B, Gajewski JL, Rondon G, Smith TL, Singletary SE, Ames FC, Sneige N, Strom EA, McNeese MD, Deisseroth AB, Champlin RE. Hortobagyi GN, et al. Among authors: deisseroth ab. J Natl Cancer Inst. 2000 Feb 2;92(3):225-33. doi: 10.1093/jnci/92.3.225. J Natl Cancer Inst. 2000. PMID: 10655439 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page